Stem cell injection aims to restore vision in dry AMD patients

NCT ID NCT03178149

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tests a stem cell therapy called ASP7317 for people with geographic atrophy, the advanced form of dry age-related macular degeneration that causes central vision loss. The treatment involves injecting special cells under the retina to replace damaged ones. Participants will take immune-suppressing drugs for a short time to prevent rejection. The main goal is to check safety and tolerability in 42 older adults with moderate to severe vision loss.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGE-RELATED MACULAR DEGENERATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Deep Blue Retina

    RECRUITING

    Southaven, Mississippi, 38671, United States

  • Emory University Eye Center

    RECRUITING

    Atlanta, Georgia, 30322, United States

  • Jules Stein Eye Institute

    RECRUITING

    Los Angeles, California, 90095, United States

  • Kaiser Permanente Riverside Medical Center

    RECRUITING

    Riverside, California, 92505, United States

  • Mass Eye and Ear Infirmary Ophthalmology Clinical Research Office

    WITHDRAWN

    Boston, Massachusetts, 02114, United States

  • Mid-Atlantic Retina

    RECRUITING

    Philadelphia, Pennsylvania, 19107, United States

  • NJ Retina

    WITHDRAWN

    New Brunswick, New Jersey, 08901, United States

  • Ophthalmic Consultants of Boston

    RECRUITING

    Boston, Massachusetts, 02114, United States

  • Retina Consultants of Southwest Florida & National Ophthalmic Research Institute

    WITHDRAWN

    Fort Myers, Florida, 33912, United States

  • Retina Foundation of the Southwest

    RECRUITING

    Dallas, Texas, 75231, United States

  • Retina Specialty Institute

    RECRUITING

    Pensacola, Florida, 35203, United States

  • Retinal Consultants of Arizona LTD, Retinal Research Institute

    WITHDRAWN

    Phoenix, Arizona, 85053, United States

  • Spokane Eye Clinical Research

    RECRUITING

    Spokane, Washington, 99204, United States

  • Stanford University Byers Eye Institute

    RECRUITING

    Palo Alto, California, 94303, United States

  • Tennessee Retina, PC

    WITHDRAWN

    Nashville, Tennessee, 37203, United States

  • University Retina and Macula Associates

    RECRUITING

    Oak Forest, Illinois, 60452, United States

  • University of Michigan Kellog Eye Center

    RECRUITING

    Ann Arbor, Michigan, 48105, United States

  • University of Washington

    WITHDRAWN

    Seattle, Washington, 98104, United States

  • Valley Retina Institute

    COMPLETED

    McAllen, Texas, 78503, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.